207 related articles for article (PubMed ID: 10198778)
21. Lipid flopping in the liver.
Linton KJ
Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
23. Genetic defects in hepatocanalicular transport.
Thompson R; Jansen PL
Semin Liver Dis; 2000; 20(3):365-72. PubMed ID: 11076402
[TBL] [Abstract][Full Text] [Related]
24. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Oude Elferink RP; Paulusma CC
Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
[TBL] [Abstract][Full Text] [Related]
25. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis.
El-Guindi MA; Sira MM; Hussein MH; Ehsan NA; Elsheikh NM
Ann Hepatol; 2016; 15(2):222-9. PubMed ID: 26845599
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
[TBL] [Abstract][Full Text] [Related]
27. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.
Figge A; Lammert F; Paigen B; Henkel A; Matern S; Korstanje R; Shneider BL; Chen F; Stoltenberg E; Spatz K; Hoda F; Cohen DE; Green RM
J Biol Chem; 2004 Jan; 279(4):2790-9. PubMed ID: 14570929
[TBL] [Abstract][Full Text] [Related]
28. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis.
De Vree JM; Ottenhoff R; Bosma PJ; Smith AJ; Aten J; Oude Elferink RP
Gastroenterology; 2000 Dec; 119(6):1720-30. PubMed ID: 11113093
[TBL] [Abstract][Full Text] [Related]
29. Control analysis of biliary lipid secretion.
Groen AK; Elferink RP; Tager JM
J Theor Biol; 1996 Oct; 182(3):427-36. PubMed ID: 8944177
[TBL] [Abstract][Full Text] [Related]
30. Canalicular ABC transporters and liver disease.
Nicolaou M; Andress EJ; Zolnerciks JK; Dixon PH; Williamson C; Linton KJ
J Pathol; 2012 Jan; 226(2):300-15. PubMed ID: 21984474
[TBL] [Abstract][Full Text] [Related]
31. Overview of Progressive Familial Intrahepatic Cholestasis.
Hassan S; Hertel P
Clin Liver Dis; 2022 Aug; 26(3):371-390. PubMed ID: 35868680
[TBL] [Abstract][Full Text] [Related]
32. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
33. Genetic defects in hepatobiliary transport.
Elferink RO; Groen AK
Biochim Biophys Acta; 2002 Mar; 1586(2):129-45. PubMed ID: 11959455
[TBL] [Abstract][Full Text] [Related]
34. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
35. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
Strautnieks SS; Bull LN; Knisely AS; Kocoshis SA; Dahl N; Arnell H; Sokal E; Dahan K; Childs S; Ling V; Tanner MS; Kagalwalla AF; Németh A; Pawlowska J; Baker A; Mieli-Vergani G; Freimer NB; Gardiner RM; Thompson RJ
Nat Genet; 1998 Nov; 20(3):233-8. PubMed ID: 9806540
[TBL] [Abstract][Full Text] [Related]
36. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
Sticova E; Jirsa M; Pawłowska J
Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
[TBL] [Abstract][Full Text] [Related]
37. ABC transporters in lipid transport.
Borst P; Zelcer N; van Helvoort A
Biochim Biophys Acta; 2000 Jun; 1486(1):128-44. PubMed ID: 10856718
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
39. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
40. Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.
Harris MJ; Le Couteur DG; Arias IM
J Gastroenterol Hepatol; 2005 Jun; 20(6):807-17. PubMed ID: 15946126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]